RecruitingNot ApplicableNCT06655636

Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors

Assisting Stroke Survivors With Engineering Technology (ASSET): Design Project D3: Exoskeletal Networks for Forearm Supination


Sponsor

Shirley Ryan AbilityLab

Enrollment

30 participants

Start Date

Dec 4, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the safety, feasibility, and efficacy of an exoskeletal network of passive, multi-joint springs for forearm supination. Also known as the forearm ExoNET, the device is a passive, robotic device that will properly assist forearm supination in the post-stroke adult population.


Eligibility

Min Age: 40 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Device tuned to Anti-Assistance, Device tuned to Assistance, and others for people with cerebral vascular accident and stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 40 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDevice tuned to Assistance

The device spring components will be tuned to produce an assistive supination torque on the forearm.

DEVICEDevice tuned to Sham (Slack Springs)

The device spring components will be tuned to slack springs to serve as a placebo. The user will think they are receiving forces but in reality the device will not be providing any forces.

DEVICEDevice tuned to Anti-Assistance

The device spring components will be tuned to produce a resistive supination torque on the forearm.


Locations(1)

Shirley Ryan AbilityLab

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06655636


Related Trials